Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2476 per EA under NDC 31722044590. Its NADAC has been published 25 times since Jan 7, 2026.
The Low Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5; 20 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722044590
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209591On Market Since
2/14/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 25 times since Jan 7, 2026, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2476 per EA |
|---|---|
| All-time high | $0.2476 (Jun 24, 2026) |
| All-time low | $0.2347 (Apr 22, 2026) |
| 52-week high | $0.2476 |
| 52-week low | $0.2347 |
| Median price | $0.2410 |
| Average price | $0.2411 |
| Largest weekly change | +4.4% (Jan 21, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Camber Pharmaceuticals Inc., is $0.2476 per EA (NDC 31722044590), effective Jun 24, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has risen 4.7%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Jan 7, 2026, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2347 (Apr 22, 2026) to a high of $0.2476 (Jun 24, 2026), with a median of $0.2410 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 5-20 MG, is $0.2412 per EA — about 3% below AMLODIPINE-OLMESARTAN 5-20 MG.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 31722044590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification